Literature DB >> 14218486

AN INVESTIGATION OF TROPICAL SPLENOMEGALY AT MULAGO HOSPITAL, KAMPALA, UGANDA.

P D MARSDEN, M S HUTT, N E WILKS, A VOLLER, V BLACKMAN, K K SHAH, D H CONNOR, P J HAMILTON, J G BANWELL, H F LUNN.   

Abstract

Keywords:  BIOPSY; DIAGNOSIS, DIFFERENTIAL; HEMATOLOGIC DISEASES; LIVER CYTOLOGY; LIVER FUNCTION TESTS; LYMPHOCYTES; METABOLISM; PATHOLOGY; PLASMA CELLS; SPLENOMEGALY; TROPICAL MEDICINE; UGANDA

Mesh：

Year:  1965        PMID： 14218486      PMCID： PMC2165011          DOI： 10.1136/bmj.1.5427.89

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  12 in total

1.  FLUORESCENT ANTIBODY METHODS AND THEIR USE IN MALARIA RESEARCH.

Authors:  A VOLLER
Journal:  Bull World Health Organ       Date:  1964       Impact factor: 9.408

2.  ABNORMAL SPLENOVENOGRAMS IN NON-CIRRHOTIC PATIENTS WITH PORTAL HYPERTENSION AND MARKED SPLENOMEGALY.

Authors:  P D MARSDEN; M S HUTT; J G BANWELL
Journal:  J Trop Med Hyg       Date:  1964-10

3.  MALARIAL ANTIBODIES IN IDIOPATHIC SPLENOMEGALY IN UGANDA.

Authors:  D A GEBBIE; P J HAMILTON; M S HUTT; P D MARSDEN; A VOLLER; N E WILKS
Journal:  Lancet       Date:  1964-08-22       Impact factor: 79.321

4.  [The etilogy of macroglobulinemias observed in Africa].

Authors:  G CHARMOT; R VARGUES
Journal:  Sem Hop       Date:  1963-06-08

5.  Portal hypertension and gross splenomegaly in Uganda.

Authors:  H M LEATHER
Journal:  Br Med J       Date:  1961-01-07

6.  Determination of the sites of red-cell destruction using 51Cr-labelled cells.

Authors:  N C HUGHES JONES; L SZUR
Journal:  Br J Haematol       Date:  1957-07       Impact factor: 6.998

7.  Chronic splenomegaly.

Authors:  R N CHAUDHURI; T K SAHA; S P BASU; A M MUKHERJEE; M N R CHAUDHURI
Journal:  Indian J Med Res       Date:  1956-04       Impact factor: 2.375

8.  The use of the isotope 51Cr as a label for red cells.

Authors:  P L MOLLISON; N VEALL
Journal:  Br J Haematol       Date:  1955-01       Impact factor: 6.998

9.  Syndrome of splenomegaly, anaemia, and hepatomegaly often left-lobed, in South Arabia.

Authors:  A L FAWDRY
Journal:  Trans R Soc Trop Med Hyg       Date:  1955-07       Impact factor: 2.184

10.  Intrasplenic pressure as index of portal venous pressure.

Authors:  M ATKINSON; S SHERLOCK
Journal:  Lancet       Date:  1954-06-26       Impact factor: 79.321
View more
  10 in total

1.  Serum immunoglobulin levels in tropical splenomegaly syndrome in New Guinea.

Authors:  J V Wells
Journal:  Clin Exp Immunol       Date:  1968-11       Impact factor: 4.330

2.  Red cell autoantibodies in ugandan sera.

Authors:  S Amsel; E C Ssebabi; E Nzaro
Journal:  Clin Exp Immunol       Date:  1974-04       Impact factor: 4.330

3.  Familial cases of endomyocardial fibrosis in Uganda.

Authors:  A K Patel; J L Ziegler; P G D'Arbela; K Somers
Journal:  Br Med J       Date:  1971-11-06

4.  Clinical features of endomyocardial fibrosis of the right ventricle.

Authors:  K Somers; D P Brenton; N K Sood
Journal:  Br Heart J       Date:  1968-05

5.  Tropical splenomegaly syndrome.

Authors: 
Journal:  Br Med J       Date:  1970-08-15

6.  Pathology of malaria in West Africa.

Authors:  G M Edington
Journal:  Br Med J       Date:  1967-03-25

7.  Anaemia in pregnancy associated with "big spleen disease".

Authors:  P J Hamilton; D A Gebbie; M S Hutt; F Lothe; N E Wilks
Journal:  Br Med J       Date:  1966-09-03

8.  Association of elevated serum glycoprotein gp70 with increased gp70 immune complex formation and accelerated lupus nephritis in autoimmune male BXSB mice.

Authors:  S Izui; I Hara; L M Hang; J H Elder; P J McConahey; F J Dixon
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

9.  Splenomegaly in New Guinea.

Authors:  P D Marsden; D H Connor; A Voller; A Kelly; F D Schofield; M S Hutt
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408

10.  (NZW x BXSB)F1 hybrid. A model of acute lupus and coronary vascular disease with myocardial infarction.

Authors:  L M Hang; S Izui; F J Dixon
Journal:  J Exp Med       Date:  1981-07-01       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.